Strategic Investment Advisors MI Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Strategic Investment Advisors MI trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 17.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,595 shares of the healthcare conglomerate’s stock after selling 545 shares during the period. Strategic Investment Advisors MI’s holdings in UnitedHealth Group were worth $1,313,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group during the 3rd quarter worth $27,000. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $30,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth $32,000. Finally, Quarry LP grew its position in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $532.26 on Monday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a 50 day moving average price of $541.04 and a 200 day moving average price of $564.34. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.83 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.58%. UnitedHealth Group’s payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.